- Home
- ESEA vs DCTH Comparison
ESEA vs DCTH Comparison
Compare ESEA & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- DCTH
- Stock Information
- Founded
- ESEA 2005
- DCTH 1988
- Country
- ESEA Greece
- DCTH United States
- Employees
- ESEA N/A
- DCTH N/A
- Industry
- ESEA Marine Transportation
- DCTH Medical/Dental Instruments
- Sector
- ESEA Consumer Discretionary
- DCTH Health Care
- Exchange
- ESEA Nasdaq
- DCTH Nasdaq
- Market Cap
- ESEA 293.8M
- DCTH 352.0M
- IPO Year
- ESEA 2006
- DCTH N/A
- Fundamental
- Price
- ESEA $35.53
- DCTH $11.34
- Analyst Decision
- ESEA Buy
- DCTH Strong Buy
- Analyst Count
- ESEA 1
- DCTH 4
- Target Price
- ESEA $53.00
- DCTH $21.50
- AVG Volume (30 Days)
- ESEA 49.2K
- DCTH 346.0K
- Earning Date
- ESEA 02-19-2025
- DCTH 11-08-2024
- Dividend Yield
- ESEA 6.75%
- DCTH N/A
- EPS Growth
- ESEA 3.12
- DCTH N/A
- EPS
- ESEA 16.28
- DCTH N/A
- Revenue
- ESEA $208,648,067.00
- DCTH $22,644,000.00
- Revenue This Year
- ESEA $13.85
- DCTH $1,605.13
- Revenue Next Year
- ESEA $6.69
- DCTH $111.67
- P/E Ratio
- ESEA $2.18
- DCTH N/A
- Revenue Growth
- ESEA 13.90
- DCTH 945.91
- 52 Week Low
- ESEA $30.78
- DCTH $3.70
- 52 Week High
- ESEA $50.92
- DCTH $13.30
- Technical
- Relative Strength Index (RSI)
- ESEA 40.82
- DCTH 51.29
- Support Level
- ESEA $32.93
- DCTH $10.75
- Resistance Level
- ESEA $34.89
- DCTH $13.30
- Average True Range (ATR)
- ESEA 1.49
- DCTH 0.70
- MACD
- ESEA -0.07
- DCTH -0.12
- Stochastic Oscillator
- ESEA 33.33
- DCTH 23.13
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.